Global Health Limited Stock

Equities

MEDANTA

INE474Q01031

Healthcare Facilities & Services

End-of-day quote NSE India S.E. 06:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
1,398 INR -1.71% Intraday chart for Global Health Limited +1.31% +45.79%
Sales 2024 * 33.47B 402M Sales 2025 * 39.24B 471M Capitalization 375B 4.51B
Net income 2024 * 4.92B 59.15M Net income 2025 * 6.26B 75.17M EV / Sales 2024 * 11.1 x
Net cash position 2024 * 5.36B 64.36M Net cash position 2025 * 6.69B 80.37M EV / Sales 2025 * 9.4 x
P/E ratio 2024 *
75.5 x
P/E ratio 2025 *
59.3 x
Employees 7,829
Yield 2024 *
0.2%
Yield 2025 *
0.24%
Free-Float 31.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.71%
1 week+1.31%
Current month+5.84%
1 month+9.20%
3 months+28.46%
6 months+81.92%
Current year+45.79%
More quotes
1 week
1 332.35
Extreme 1332.35
1 440.00
1 month
1 278.25
Extreme 1278.25
1 448.00
Current year
938.45
Extreme 938.45
1 513.90
1 year
485.05
Extreme 485.05
1 513.90
3 years
390.55
Extreme 390.55
1 513.90
5 years
390.55
Extreme 390.55
1 513.90
10 years
390.55
Extreme 390.55
1 513.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 10-11-30
78 -
Chief Tech/Sci/R&D Officer - 14-11-05
Members of the board TitleAgeSince
Director/Board Member 64 21-07-07
Director/Board Member 67 21-03-22
Chairman 78 -
More insiders
Date Price Change Volume
24-04-23 1,398 -1.71% 218,410
24-04-22 1,423 +1.35% 128,408
24-04-19 1,404 +2.24% 154,489
24-04-18 1,373 -0.98% 118,361
24-04-16 1,386 +0.45% 103,360

End-of-day quote NSE India S.E., April 22, 2024

More quotes
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. It provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
1,398 INR
Average target price
1,344 INR
Spread / Average Target
-3.88%
Consensus
  1. Stock Market
  2. Equities
  3. MEDANTA Stock